Results 41 to 50 of about 152,494 (287)

G3/2019/400261

, 2019
Supplementary Materials forTranscriptome analysis alk-SMase knockout mice reveals the effect of alkaline sphingomyelinase on ...
  +4 more sources

G3 Nöroendokrin Tümörlere Yaklaşım Approach to G3 Neuroendocrine Tumors

Nuclear Medicine Seminars, 2021
G3 neuroendocrine tumors (G3 NET) have >20% Ki-67 index and >20 mitoses/10 high-power field but have well-differentiated tumor morphology compared to neuroendocrine carcinomas. They have poor prognosis compared to G2 tumors but have better prognosis than G3 carcinomas. In this review chracteristics and clinical approach to G3 NET is summarized.
openaire   +2 more sources

A Real Estate Development Risk Rating Model Using Machine Learning and Multidimensional Data (RED RM)

Real Estate Management and Valuation
The real estate sector is a cornerstone of economic development, significantly contributing to GDP and employment. For financial institutions, assessing the creditworthiness of developers and buyers is crucial to mitigate credit risks and maintain ...
Berrada Imane Rhzioual, Barramou Fatimazahra, Alami Omar Bachir   +2 more
doaj   +1 more source

Pre-school childcare and inequalities in child development

SSM: Population Health, 2021
Centre-based childcare may benefit pre-school children and alleviate inequalities in early childhood development, but evidence on socio-emotional and physical health outcomes is limited. Data were from the UK Millennium Cohort Study (n = 14,376). Inverse-
Michael J. Green, Anna Pearce, Alison Parkes, Elaine Robertson, S.Vittal Katikireddi   +4 more
doaj   +1 more source

Engineered extracellular vesicles enriched with the miR‐214/199a cluster enhance the efficacy of chemotherapy in ovarian cancer

Molecular Oncology, EarlyView.
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang, Ayesha Alvero, Yi Qin, Mingjin Wang, Alexandra Fox, Yanfeng Li, Michael Millman, Amy Kemper, Gil Mor, Xian Shuang Liu, Michael Chopp, Zheng Gang Zhang, Yi Zhang   +12 more
wiley   +1 more source

Practitioner Enquiry as Lifelong Teacher Education for Inclusion

Education Sciences
This article focuses on the use of a practitioner enquiry (PE) course to develop teacher education for inclusion, particularly when referring to continuous professional development (CPD).
Ines Alves, Annie Christodoulidis, Jeff Carpenter, Victoria Maria Hogg   +3 more
doaj   +1 more source

НЭО G3 — новая подгруппа, новые подходы [PDF]

, 2021
Введение: Подгруппа нейроэндокринных опухолей (НЭО) G3 впервые была выделена в 2017 году. Данная подгруппа опухолей отличается от смежных групп НЭО G2 и крупноклеточных нейроэндокринный карцином (КНЭК) по своим молекулярным и морфологическим свойствам ...
Г. Ю. Чемерис, Е. В. Артамонова, Е. В. Евдокимова, В. В. Делекторская   +3 more
core   +2 more sources

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Ips Poy g3 Data Set [PDF]

, 2009
Ips Poy g3 Data ...
Anthony I. Cognato (303246), Alfried P. Vogler (69119)   +1 more
core   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source